Reaction Details
Report a problem with these data
Report a problem with these dataTarget
Pro-glucagon
Ligand
BDBM142021
Substrate
n/a
Meas. Tech.
SPA Assay
pH
7.4±n/a
Ki
280±n/a nM
Citation
Didiuk, M; Filipski, KJ; Guzman-Perez, A; Lee, EC; Pfefferkorn, JA; Stevens, B; Tu, M Quinolinyl glucagon receptor modulators US Patent US8927577 Publication Date 1/6/2015 More Info.:
Target
Name:
Pro-glucagon
Synonyms:
GCG | GLUC_HUMAN | Glucagon | Glucagon receptor (GCGR)
Type:
Enzyme
Mol. Mass.:
20907.95
Organism:
Homo sapiens (Human)
Description:
P01275
Residue:
180
Sequence:
MKSIYFVAGLFVMLVQGSWQRSLQDTEEKSRSFSASQADPLSDPDQMNEDKRHSQGTFTSDYSKYLDSRRAQDFVQWLMNTKRNRNNIAKRHDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRGRRDFPEEVAIVEELGRRHADGSFSDEMNTILDNLAARDFINWLIQTKITDRK
Inhibitor
Name:
BDBM142021
Synonyms:
US8927577, 2
Type:
Small organic molecule
Emp. Form.:
C24H27N3O3
Mol. Mass.:
405.4895
SMILES:
CCC[C@H](Nc1nc2ccccc2cc1C)c1ccc(cc1)C(=O)NCCC(O)=O |r|
Structure:
